scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.HYP.16.6.617 |
P698 | PubMed publication ID | 2246029 |
P50 | author | Sverre E. Kjeldsen | Q45903512 |
P2093 | author name string | L Krause | |
E Johnson | |||
K Jones | |||
A Mejia | |||
N Schork | |||
S Julius | |||
C van de Ven | |||
J Petrin | |||
M A Sekkarie | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | arterial hypertension | Q41861 |
Tecumseh | Q2463798 | ||
P304 | page(s) | 617-623 | |
P577 | publication date | 1990-12-01 | |
P1433 | published in | Hypertension | Q5958695 |
P1476 | title | "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. | |
P478 | volume | 16 |
Q77334838 | "White coat effect" induced by therapist's presence during speech therapy for stroke rehabilitation: a single case study |
Q40948163 | A new diagnostic classification for hypertension. |
Q40693524 | Abnormalities of autonomic nervous control in human hypertension |
Q73696946 | Accuracy of telemedical home blood pressure measurement in the diagnosis of hypertension |
Q34371018 | Ambulatory blood pressure measurement in general practice |
Q52211661 | Ambulatory blood pressure monitoring and diagnostic errors in hypertension: a Bayesian approach. |
Q36601808 | Ambulatory blood pressure monitoring: a guide for general practitioners |
Q36690764 | Applications of 24-hour noninvasive ambulatory blood pressure monitoring |
Q37124518 | Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease |
Q73553107 | Blood pressure biofeedback treatment of white-coat hypertension |
Q33830998 | Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey |
Q44354160 | Circulating homocysteine levels in sustained and white coat hypertension |
Q38118933 | Clinical significance of home blood pressure and its possible practical application |
Q73133170 | Comparison of self-reported home blood pressure measurements with automatically stored values and ambulatory blood pressure |
Q72335040 | Confounders of auscultatory blood pressure measurement |
Q51718281 | Correlation of repeated measurements of home blood pressure on one occasion and diagnosis of hypertension: study by measurement over seven consecutive days. |
Q48831883 | Current role of automated ambulatory blood pressure and self-measured blood pressure determinations in clinical practice |
Q51945969 | Determinants of the white-coat effect in normotensives and never-treated mild hypertensives. |
Q37913971 | Diagnosis and management of patients with white-coat and masked hypertension |
Q38776339 | Endothelial Dysfunction and Hypertension |
Q68219569 | Heredity and hypertension: Impact on metabolic characteristics |
Q37869178 | High prevalence of Chlamydia pneumoniae antibodies in white-coat hypertensives |
Q36964644 | Higher Blood Pressure Variability in White Coat Hypertension; from the Korean Ambulatory Blood Pressure Monitoring Registry |
Q37218788 | Identification of hypertension and efficacy of treatment in a rural Australian population |
Q36975611 | Impact of white-coat hypertension on microvascular complications in type 2 diabetes |
Q34028599 | Importance of various methods of blood pressure measurement in clinical trials |
Q46437379 | Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension |
Q50931829 | Interactive action of the white-coat effect and the blood pressure levels on cardiovascular complications in hypertension. |
Q37423824 | Is There Any Correlation between Insulin Resistance and Nitrate Plasma Concentration in White Coat Hypertensive Patients? |
Q41681151 | Is White Coat Hypertension Associated With Arterial Disease or Left Ventricular Hypertrophy? |
Q34394794 | Is white-coat hypertension innocent? |
Q51797042 | Jananese Society of Hypertension (JSH) Guidelines for Self-Monitoring of Blood Pressure at Home |
Q48585304 | Left Ventricular Function Assessed by One-Point Carotid Wave Intensity in Newly Diagnosed Untreated Hypertensive Patients |
Q35266321 | Measurement and interpretation of blood pressure |
Q80413323 | Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function |
Q33969773 | Modern approaches to blood pressure measurement |
Q44777694 | Oxidative stress in white coat hypertension; role of paraoxonase |
Q34028593 | Prehypertension: a possible target for antihypertensive medication |
Q34032102 | Prevalence and predictors of white-coat response in patients with treated hypertension |
Q43425361 | Prevalence of hypertension and rate of blood pressure control as assessed by home blood pressure measurements in a rural Japanese community, Ohasama |
Q42969987 | Relationship of dysregulation of glucose metabolism with white-coat hypertension: the Ohasama study |
Q33680528 | Reliability of patients measuring blood pressure at home: prospective observational study |
Q34706868 | Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults |
Q48807353 | Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. |
Q44834649 | Stroke risk in treated hypertension based on home blood pressure: the Ohasama study |
Q52861427 | Sympathetic neural mechanisms in white-coat hypertension. |
Q54159278 | Target Organ Status and Serum Lipids in Patients With White Coat Hypertension |
Q44756168 | Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? |
Q73279649 | Tele-monitoring of Home Blood Pressure in Treated Hypertensive Patients |
Q84730964 | The Japanese Society of Hypertension Guidelines for Self-monitoring of Blood Pressure at Home (Second Edition) |
Q40516326 | The defense reaction: a common denominator of coronary risk and blood pressure in neurogenic hypertension? |
Q41065978 | The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension |
Q50776211 | Transiently elevated diastolic blood pressure is associated with a gender-dependent effect on cardiovascular risk. |
Q34459056 | Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications |
Q64116629 | What is the optimal cut-off threshold in self-home blood pressure measurement?: A cohort study according to STROBE statement |
Q40387998 | White coat hypertension and related phenomena. A clinical approach. |
Q51565341 | White coat hypertension in a general practice. Prevalence, cardiovascular risk factors and clinical implications. |
Q43731591 | White coat hypertension: a follow-up |
Q84919170 | White coat hypertension: addressing the 10 most important questions |
Q24669903 | White coat hypertension: relevance to clinical and emergency medical services personnel |
Q34994397 | White coat hypertension: understanding the concept and examining the significance |
Q50935870 | White coat phenomenon, anxiety and endothelial function in healthy normotensive elderly subjects. |
Q83867824 | [Appraisal of self-measurement of blood pressure in the diagnosis of isolated clinical hypertension. VAMPAHICA study] |
Q73353152 | [Heart rate and isolated clinical tachycardia in hypertensive patients] |
Q74227642 | [Self-measurement of arterial pressure: a critical review] |
Search more.